Figure 1.
Figure 1. Activated FLT3 levels in patient responsive to ASP2215; pre-treatment (A) and post-treatment (B)

Activated FLT3 levels in patient responsive to ASP2215; pre-treatment (A) and post-treatment (B)

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal